Perspectives on the burden of pneumonia in children

Kim Mulholland1

  • 1London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK. kim.mulholland@ishtm.ac.uk

Vaccine
|October 27, 2006
PubMed

Insights

Early 20th-century infant mortality from pneumonia was high. While antibiotics helped, improvements in nutrition and childcare significantly reduced pneumonia deaths before widespread antibiotic use.

Area of Science:

  • Pediatrics
  • Public Health
  • Medical History

Background:

  • Infant mortality in the early 20th century US was alarmingly high, with pneumonia accounting for a significant portion of deaths.
  • Childhood pneumonia presented a high case fatality rate in the pre-antibiotic era, disproportionately affecting infants.

Purpose of the Study:

  • To analyze historical trends in pneumonia mortality among infants in the US.
  • To evaluate the impact of antibiotics versus other factors on reducing pneumonia deaths.
  • To inform current strategies for pneumonia control.

Main Methods:

  • Historical data analysis of infant mortality rates and causes of death in the US from 1900.
  • Comparison of mortality trends before and after the introduction of antibiotics.
  • Review of contributing factors to pneumonia mortality reduction.

Main Results:

  • Pneumonia was a leading cause of infant death in the early 1900s.
  • Antibiotics reduced pneumonia mortality, but the most substantial decline occurred prior to their widespread use.
  • Improvements in nutrition and childcare likely played a major role in early mortality reduction.

Conclusions:

  • Historical data indicates that non-medical interventions like improved nutrition and childcare were critical in reducing early 20th-century pneumonia mortality.
  • Current pneumonia control strategies focusing on case management and vaccines may benefit from a broader, more holistic approach informed by historical context.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: